Cancer has been globally affecting 10million people and it is expected to increase by 2.4% by 2020, reaching to 14 million. Cervical Cancer is a form of cancer that forms in the cervix region of the female reproductive system. The cancer is usually a slow developing type of cancer which may or may not show symptoms of the diseases. The cancer is usually caused by the HPV (Human papilloma virus) infection. In 2013, the number of new cases in the United States was estimated to be 12,340 and the number of deaths due to cervical cancer was estimated to be 4,030.
The factors that are driving the cervical cancer market are HPV infection, women having many sexual partners, women getting sexually active at an early age, smoking, certain genetic factors and weak immune system. The factors limiting the growth of this market are the complex tests that require many sampling instruments, need of trained pathologists & cyto-technicians, need for continuous monitoring to obtain high quality results. Due to the above factors, it takes months to obtain a report and it adds to the difficulty of following-up with women patients. The opportunities for the growth of this market are exploring new markets where the treatment is not available yet and reducing the cost of the treatment. These factors can provide a profitable opportunity for efficient and effective treatment.
The key players profiled in this report are Abbott laboratories, Becton, Dickenson and co., Roche diagnostics, Johnson & Johnson, Merck, Pfizer, Bristol-Myers Squibb, Digene corp., Dendreon corp., and SANOFI.
KEY MARKET SEGMENT
BY TEST TYPES
SIMILAR MARKET STUDIES
2016 Global Respiratory Syncytial Virus (RSV) Diagnostic Report is a professional and in-depth research report on the world's major regional market conditions of the Respiratory Syncytial Virus (RSV) Diagnostic industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The ...
August 2016 | $2850 | View Details >>
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.This new 350-page report from VPGMarketResearch.com contains 90 tables and provides analysis of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed ...
March 2017 | $0 | View Details >>
This new report contains 248 pages, 15 tables, and presents a comprehensive analysis of the US hospital hematology and flow cytometry markets, including: Major issues pertaining to the US hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.Five-year volume and sales forecasts for major hematology and flow cytometry tests performed in US hospitals.
November 2014 | $4400 | View Details >>
DC-AC Power Inverter Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea ...
April 2017 | $2850 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research